We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
After announcing this year’s Fierce 15 winners, we invited their executives to the Drug Development Forum in Boston to discuss some of the pivotal moments leading up to their win.
As the pharma and biotech industry rolls to the end of another quarter, some investors are keen to pick up information about possible stock surges due to positive pipelines, favorable regulatory news and the overall economic health of the country.